How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AD

NYSE:ADCT
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AD

ADC Therapeutics SANYSE ADCT Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNYS - New York Stock Exchange, Inc

FAIR VALUE

Is ADCT undervalued compared to its fair value?

The fair value of ADCT stock is hidden USD. Relative to the market price of 3.44 USD ADC Therapeutics SA is hidden.

ADC Therapeutics SA is a clinical-stage biotechnology company. The company is headquartered in Epalinges, Vaud and currently employs 317 full-time employees. The company went IPO on 2020-05-15. The company develops antib...[More about valuation]

ADC Therapeutics SA Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.353 $B

Price:

3.44 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.565

FINANCIALS

ADC Therapeutics SA financial for reporting period

Income Statement

0.018 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.034 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.047 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.018 B 100%
0.016 B 86%
-0.034 B -186%
-0.047 B -258%

Balance Sheet

0.31 B
-0.19 B


Financial Position Analysis

Assets

0.31 B
Current Assets
0.29 B
Total non-current assets
0.018 B

Total current liabilities
0.063 B
Total non-current liabilities
0.44 B

Cash Flow Statement

-0.045 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.044 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

ADC Therapeutics SA fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-524 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-93 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is ADCT attractive for investment based on fundamental analysis?

ADCT stock rating is hidden. ADC Therapeutics SA is a hidden by Eyestock methodology.

Get ADCT Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-314

Gross Margin:

95

CFO / Debt ratio:

hidden

Current ratio:

4.888

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

ADCT analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for ADCT to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

ADC Therapeutics SA competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

ADC Therapeutics SA dividends

ADCT dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About ADCT stock

About the company ADC Therapeutics SA

Market cap $B

0.353

Dividend yield

Shares outstanding

80.6425 B

ADC Therapeutics SA is a clinical-stage biotechnology company. The company is headquartered in Epalinges, Vaud and currently employs 317 full-time employees. The company went IPO on 2020-05-15. The company develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. The company employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The firm has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. The company serves customers in the United States, Switzerland, and the United Kingdom.

ADCT profile

  • Ticker

    ADCT

  • Country

    Switzerland

  • Exchange

    XNYS - New York Stock Exchange, Inc

  • Report currency

    USD - US dollar

  • IPO date

    15 May 2020

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    317

  • City

    Epalinges

  • Address

    Biopole, route de la Corniche 3B

  • Cusip

    H0036K147